Law stated as of 02 Mar 2015 • USA (National/Federal) |
Company | Form 10-K for Fiscal Year Ended | Filing Date | Location of Disclosure |
AbbVie Inc. | December 31, 2014 | February 20, 2015 | |
Abbott Laboratories | December 31, 2014 | February 27, 2015 | |
Allergan, Inc. | December 31, 2014 | February 19, 2015 | |
Amgen Inc. | December 31, 2014 | February 19, 2015 | |
Biogen Inc. (fka Biogen Idec Inc.) | December 31, 2014 | February 4, 2015 | |
Bristol-Myers Squibb Company | December 31, 2014 | February 13, 2015 | |
Celgene Corporation | December 31, 2014 | February 20, 2015 | |
Eli Lilly and Company | December 31, 2014 | February 19, 2015 | |
Gilead Sciences, Inc. | December 31, 2014 | February 25, 2015 | |
Johnson & Johnson | December 28, 2014 | February 24, 2015 | |
Merck & Co., Inc. | December 31, 2014 | February 27, 2015 | |
Mylan Inc. | December 31, 2014 | March 2, 2015 | |
Pfizer Inc. | December 31, 2014 | February 27, 2015 |